Top

Published in:

Open Access 01-10-2011 | Editorial

Time to act on headache disorders

Authors: Timothy J. Steiner, Lars Jacob Stovner, Tarun Dua, Gretchen L. Birbeck, Rigmor Jensen, Zaza Katsarava, Paolo Martelletti, S. Saxena

Published in: The Journal of Headache and Pain | Issue 5/2011

Excerpt

Headache is felt, at some time, by nearly everybody, and almost half the world’s adults at any point in time have recent personal experience of one or more headache disorders [1]. In the Global Burden of Disease Study, updated in 2004, migraine on its own accounted for 1.3% of all years of life lost to disability worldwide [2]. Other headache disorders, collectively, may be responsible for a similar burden [1]. Yet, much is unknown about the public-health impact of these disorders. Not only is our view incomplete of the global burden attributable to headache disorders, but also our knowledge of health-care resource allocation to them is scant. …

Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27:193–210, 17381554, 10.1111/j.1468-2982.2007.01288.xCrossRefPubMed

World Health Organization (2004) Geneva, WHO http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html

World Health Organization (2011) Atlas of headache disorders and resources in the world 2011. WHO, Geneva

Steiner TJ (2004) Lifting the burden: the global campaign against headache. Lancet Neurol 3:204–205, 15039030, 10.1016/S1474-4422(04)00703-3, 1:STN:280:DC%2BD2c7nvFCmtQ%3D%3DCrossRefPubMed

Steiner TJ, Birbeck GL, Jensen R, Katsarava Z, Martelletti P, Stovner LJ (2010) Lifting the burden: the first 7 years. J Headache Pain 11:451–455, 21080023, 10.1007/s10194-010-0264-6PubMedCentralCrossRefPubMed

Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ (2000) Ergotamine in the acute treatment of migraine: a review and European consensus. Brain 123(Pt 1):9–18, 10611116, 10.1093/brain/123.1.9CrossRefPubMed

Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB (2003) The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23:519–527, 12950377, 10.1046/j.1468-2982.2003.00568.x, 1:STN:280:DC%2BD3svns1GhsQ%3D%3DCrossRefPubMed

McCrone P, Seed PT, Dowson AJ, Clark LV, Goldstein LH, Morgan M, Ridsdale L (2011) Service use and costs for people with headache: a UK primary care study. J Headache Pain. doi:10.1007/s10194-011-0362-0

Title: Time to act on headache disorders
Authors: Timothy J. Steiner
Lars Jacob Stovner
Tarun Dua
Gretchen L. Birbeck
Rigmor Jensen
Zaza Katsarava
Paolo Martelletti
S. Saxena
Publication date: 01-10-2011
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 5/2011
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1007/s10194-011-0368-7

At a glance: The STEP trials

Springer Medicine

Time to act on headache disorders

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2011

“Comorbidity” between epilepsy and headache/migraine: the other side of the same coin!

The Eurolight project: the impact of primary headache disorders in Europe. Description of methods

Classification and clinical features of headache patients: an outpatient clinic study from China

Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache

Auditory hallucinations and migraine of possible brainstem origin

The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the Prostaglandin E2 human model of headache